Yonsei Univ.
Seoul, South Korea
NCT Number: NCT00962676
For diagnosis of active tuberculosis, interferon-γ release assay based mycobacterium tuberculosis specific antigen may show higher sensitivity than tuberculin skin test in immunocompromised patients. Therefore, interferon-γ release assay have a role as a rapid diagnostic adjunctive methods for active tuberculosis in immunocompromised patients.
Looking for future studies?
Notify Me20 year and older
All sexes
Observational
Seoul, South Korea
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Looking for future studies?
Notify MeYonsei University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04121026
Actinomycetales Infections, Bacterial Infections
Abidjan, Côte d’Ivoire
View Trial DetailsNCT04618198
Actinomycetales Infections, Bacterial Infections
Sanya Juu, Tanzania
View Trial DetailsNCT04926922
Actinomycetales Infections, Bacterial Infections
Bethesda, Maryland, United States
View Trial DetailsNCT02563327
Actinomycetales Infections, Bacterial Infections
Kampala, Uganda
View Trial Details